‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented
Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara Market…
CertaraMay 23, 2025
Certainty China 2025
Date: Tuesday, September 23rdTime: 9:00 am – 5:00 pmLocation: Crowne Plaza Shanghai JinxiuCertainty by Certara…
CertaraMay 22, 2025
Certara Reports First Quarter 2025 Financial Results
RADNOR, PA— May 5, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…
CertaraMay 5, 2025
RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions
Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson…
CertaraApril 24, 2025
Certara Announces Second Annual Certainty U.S. Event
Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…
CertaraApril 22, 2025
Using cost-effectiveness models for smarter drug development and healthcare decisions
April 14, 2025 Editor’s note: This is the second in a series of four articles…
CertaraApril 14, 2025
Delivering DSUR Excellence for Multinational Biopharma
A global leader in immuno-oncology approached us for support with over 50 simple to complex…
CertaraApril 11, 2025
Standardizing Real World Data in Rare Disease: ATHN’s Journey
Learn how Certara helped ATHN standardize Real World Data for regulatory submissions, advancing rare disease…
CertaraApril 8, 2025
